| cik | 0001697862 |
| entityType | other |
| sic | 2836 |
| sicDescription | Biological Products, (No Diagnostic Substances) |
| ownerOrg | 03 Life Sciences |
| insiderTransactionForOwnerExists | 0 |
| insiderTransactionForIssuerExists | 0 |
| name | ARGENX SE |
| tickers | ARGX |
| exchanges | Nasdaq |
| ein | 000000000 |
| lei | — |
| description | — |
| website | — |
| investorWebsite | — |
| category | Large accelerated filer |
| fiscalYearEnd | 1231 |
| stateOfIncorporation | P7 |
| stateOfIncorporationDescription | Netherlands |
| addresses.mailing | street1: INDUSTRIEPARK ZWIJNAARDE 7 street2: BUILDING C B-9052 city: ZWIJNAARDE isForeignLocation: 1 foreignStateTerritory: GHENT country: Belgium countryCode: C9 |
| addresses.business | street1: INDUSTRIEPARK ZWIJNAARDE 7 street2: BUILDING C B-9052 city: ZWIJNAARDE isForeignLocation: 1 foreignStateTerritory: GHENT country: Belgium countryCode: C9 |
| phone | 32 (9) 310 34 00 |
| flags | — |
| formerNames | name: argenx N.V, from: 2017-03-01T00:00:00.000Z, to: 2017-04-21T00:00:00.000Z |